 HOLLISTON, Mass., Feb. 21, 2022 GLOBE NEWSWIRE -- Harvard Bioscience, Inc. Nasdaq: HBIO will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on March 8, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 